Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Diagnostic Imaging

  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 117 articles:
HTML format

Single Articles

    May 2021
  1. ONO M, Serruys PW, Patel MR, Escaned J, et al
    A Prospective Multicenter Validation Study for A Novel Angiography-derived Physiological Assessment Software: Rationale and Design of the Radiographic imaging Validation and EvALuation for Angio-iFR (ReVEAL iFR) study.
    Am Heart J. 2021 May 13. pii: S0002-8703(21)00124.
    PubMed     Abstract available

  2. ZANCHIN C, Koskinas KC, Ueki Y, Losdat S, et al
    Effects of the PCSK9 Antibody Alirocumab on Coronary Atherosclerosis in Patients with Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near-Infrared Spectroscopy and Optical Coherence Tomography Imaging Study Rationale and
    Am Heart J. 2021 May 2. pii: S0002-8703(21)00108.
    PubMed     Abstract available

    March 2021
  3. KITKUNGVAN D, Johnson NP, Kirkeeide R, Haynie M, et al
    Design and Rationale of The Randomized Trial of Comprehensive LifEstyle ModificatioN, Optimal Pharmacological Treatment and Utilizing PET Imaging for Quantifying and Managing Stable CoronaRy ArterY Disease (The CENTURY Study).
    Am Heart J. 2021 Mar 21. pii: S0002-8703(21)00078.
    PubMed     Abstract available

  4. CHERY GS, Kamp N, Kosinski AS, Schmidler GS, et al
    Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement.
    Am Heart J. 2021;233:151-152.

  5. DISERTORI M, Mase M, Rigoni M, Ravelli F, et al
    The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement.
    Am Heart J. 2021;233:149-150.

    February 2021
  6. GE Z, Gao XF, Kan J, Kong XQ, et al
    Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicent
    Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00053.
    PubMed     Abstract available

  7. ZHANG KW, Zhang R, Deych E, Stockerl-Goldstein KE, et al
    A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
    Am Heart J. 2021;232:137-145.
    PubMed     Abstract available

    January 2021
  8. GE Z, Kan J, Gao XF, Kong XQ, et al
    Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomized and multicenter DKCRUSH VIII trial.
    Am Heart J. 2021 Jan 16. pii: S0002-8703(21)00015.
    PubMed     Abstract available

  9. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available

  10. FAGEL ND, Amoroso G, Vink MA, Slagboom T, et al
    An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: the OPTIMA-2 randomized controlled trial.
    Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00003.
    PubMed     Abstract available

    December 2020
  11. MCCORD J, Hana A, Cook B, Hudson MP, et al
    The Role of Cardiac Testing with the 0/1-Hour High-Sensitivity Cardiac Troponin Algorithm Evaluating for Acute Myocardial Infarction.
    Am Heart J. 2020 Dec 26. pii: S0002-8703(20)30417.
    PubMed     Abstract available

  12. JOYCE J, O'Leary ET, Mah DY, Harrild DM, et al
    Cardiac resynchronization therapy improves the ventricular function of patients with Fontan physiology.
    Am Heart J. 2020;230:82-92.
    PubMed     Abstract available

    October 2020
  13. FRIEDMAN DJ, Emerek K, Kisslo J, Sogaard P, et al
    Left bundle branch block is associated with a similar Dyssynchronous phenotype in heart failure patients with Normal and reduced ejection fractions.
    Am Heart J. 2020 Oct 21. pii: S0002-8703(20)30338.
    PubMed     Abstract available

  14. IKENOUCHI T, Inaba O, Takamiya T, Inamura Y, et al
    The impact of left atrium size on selection of the pulmonary vein isolation method for atrial fibrillation: Cryoballoon or radiofrequency catheter ablation.
    Am Heart J. 2020 Oct 21. pii: S0002-8703(20)30347.
    PubMed     Abstract available

  15. JAWITZ OK, Cox ML, Ranney D, Williams JB, et al
    Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial.
    Am Heart J. 2020;228:91-97.
    PubMed     Abstract available

  16. LI Y, Wang X, Bao D, Liao Z, et al
    Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial.
    Am Heart J. 2020;228:8-16.
    PubMed     Abstract available

    September 2020
  17. GRUBB AF, Pumill CA, Greene SJ, Wu A, et al
    Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University medical center.
    Am Heart J. 2020 Sep 24. pii: S0002-8703(20)30264.
    PubMed     Abstract available

  18. BIGLER MR, Stoller M, Tschannen C, Grossenbacher R, et al
    Effect of permanent right internal mammary artery occlusion on right coronary artery supply: A randomized placebo-controlled clinical trial.
    Am Heart J. 2020 Sep 16. pii: S0002-8703(20)30259.
    PubMed     Abstract available

    August 2020
  19. LAURIDSEN MD, Rorth R, Lindholm MG, Kjaergaard J, et al
    Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005-2017: A nationwide cohort study.
    Am Heart J. 2020 Aug 27. pii: S0002-8703(20)30242.
    PubMed     Abstract available

  20. HONIGBERG MC, Pirruccello JP, Aragam K, Sarma AA, et al
    Menopausal Age and Left Ventricular Remodeling by Cardiac Magnetic Resonance Imaging Among 14,550 Women.
    Am Heart J. 2020 Aug 19. pii: S0002-8703(20)30235.
    PubMed     Abstract available

  21. BISCAGLIA S, Guiducci V, Santarelli A, Santos IA, et al
    Physiology-guided revascularization versus optimal medical therapy of non-culprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial.
    Am Heart J. 2020 Aug 18. pii: S0002-8703(20)30237.
    PubMed     Abstract available

  22. CHERY G, Kamp N, Kosinski AS, Schmidler GS, et al
    Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review.
    Am Heart J. 2020;229:52-60.
    PubMed     Abstract available

  23. KANG DY, Ahn JM, Park H, Lee PH, et al
    Comparison of optical coherence tomography-guided versus intravascular ultrasound-guided percutaneous coronary intervention: Rationale and design of a randomized, controlled OCTIVUS trial.
    Am Heart J. 2020;228:72-80.
    PubMed     Abstract available

  24. SHLOFMITZ E, Torguson R, Mintz GS, Zhang C, et al
    The IMPact on Revascularization Outcomes of intraVascular ultrasound-guided treatment of complex lesions and Economic impact (IMPROVE) trial: Study design and rationale.
    Am Heart J. 2020;228:65-71.
    PubMed     Abstract available

  25. PERITZ DC, Catino AB, Csecs I, Kaur G, et al
    High-intensity endurance training is associated with left atrial fibrosis.
    Am Heart J. 2020;226:206-213.
    PubMed     Abstract available

    July 2020
  26. STAHLI BE, Varbella F, Schwarz B, Nordbeck P, et al
    Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Am Heart J. 2020;228:98-108.
    PubMed     Abstract available

  27. HERKERT JC, Verhagen JMA, Yotti R, Haghighi A, et al
    Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
    Am Heart J. 2020;225:108-119.
    PubMed     Abstract available

  28. SILVAIN J, Cayla G, Beygui F, Range G, et al
    Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study.
    Am Heart J. 2020;225:27-37.
    PubMed     Abstract available

    June 2020
  29. ARAIZA-GARAYGORDOBIL D, Gopar-Nieto R, Martinez-Amezcua P, Cabello-Lopez A, et al
    A randomized controlled trial of lung ultrasound-guided therapy in heart failure (CLUSTER-HF study).
    Am Heart J. 2020;227:31-39.
    PubMed     Abstract available

    May 2020
  30. BOTTINOR WJ, Soslow JH, Godown J, Stoddard MF, et al
    Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging.
    Am Heart J. 2020;226:127-139.
    PubMed     Abstract available

    April 2020
  31. UNKART JT, Allison MA, Parada H Jr, Criqui MH, et al
    Sedentary time and peripheral artery disease: The Hispanic Community Health Study/Study of Latinos.
    Am Heart J. 2020;222:208-219.
    PubMed     Abstract available

  32. GALES J, Krasuski RA, Awerbach JD
    Emergency department evaluation of chest pain among adult congenital heart disease patients.
    Am Heart J. 2020;222:191-198.
    PubMed     Abstract available

  33. STEGEHUIS VE, Wijntjens GWM, van de Hoef TP, Casadonte L, et al
    Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect-combined pressure and Doppler FLOW velocity measurements (DEFINE-FLOW) trial: Rationale and trial design.
    Am Heart J. 2020;222:139-146.
    PubMed     Abstract available

  34. HAUW-BERLEMONT C, Lamhaut L, Diehl JL, Andreotti C, et al
    EMERGEncy versus delayed coronary angiogram in survivors of out-of-hospital cardiac arrest with no obvious non-cardiac cause of arrest: Design of the EMERGE trial.
    Am Heart J. 2020;222:131-138.
    PubMed     Abstract available

    March 2020
  35. YOON YH, Ahn JM, Kang DY, Park H, et al
    Pragmatic trial comparing routine versus no routine functional testing in high-risk patients who underwent percutaneous coronary intervention: Rationale and design of POST-PCI trial.
    Am Heart J. 2020;224:156-165.
    PubMed     Abstract available

  36. OSMAN M, Saleem M, Osman K, Kheiri B, et al
    Radial versus femoral access for percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: Trial sequential analysis.
    Am Heart J. 2020;224:98-104.
    PubMed     Abstract available

  37. VLACHOJANNIS GJ, Vogel RF, Wilschut JM, Lemmert ME, et al
    COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.
    Am Heart J. 2020;224:10-16.
    PubMed     Abstract available

    February 2020
  38. SONG L, Tu S, Sun Z, Wang Y, et al
    Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
    Am Heart J. 2020;223:72-80.
    PubMed     Abstract available

  39. QUESADA O, AlBadri A, Wei J, Shufelt C, et al
    Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
    Am Heart J. 2020;220:224-236.
    PubMed     Abstract available

  40. ROZENBAUM Z, Finkelstein A, Zhitomirsky S, Topilsky Y, et al
    Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Am Heart J. 2020;220:184-191.
    PubMed     Abstract available

  41. ALI-AHMED F, Dalgaard F, Al-Khatib SM
    Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management.
    Am Heart J. 2020;220:29-40.
    PubMed     Abstract available

    January 2020
  42. HOUSSANY-PISSOT S, Rosencher J, Allouch P, Bensouda C, et al
    Screening coronary artery disease with computed tomography angiogram should limit normal invasive coronary angiogram, regardless of pretest probability.
    Am Heart J. 2020 Jan 30. pii: S0002-8703(20)30034.
    PubMed     Abstract available

  43. MEAH MN, Bing R, Newby DE
    Primacy of coronary CT angiography as the gatekeeper for the cardiac catheterization laboratory.
    Am Heart J. 2020 Jan 30. pii: S0002-8703(20)30032.
    PubMed     Abstract available

  44. VALLABHAJOSYULA S, Vallabhajosyula S, Burstein B, Ternus BW, et al
    Epidemiology of in-hospital cardiac arrest complicating non-ST-segment elevation myocardial infarction receiving early coronary angiography.
    Am Heart J. 2020;223:59-64.
    PubMed     Abstract available

  45. ROMAGUERA R, Salinas P, Brugaletta S, Gomez-Lara J, et al
    Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design.
    Am Heart J. 2020;222:174-182.

  46. DUENGEN HD, Kim RJ, Zahger D, Orvin K, et al
    Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial.
    Am Heart J. 2020;224:129-137.
    PubMed     Abstract available

  47. UDELSON JE, Lewis GD, Shah SJ, Zile MR, et al
    Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved
    Am Heart J. 2020;222:183-190.
    PubMed     Abstract available

  48. KALBACHER D, Tigges E, Boekstegers P, Puls M, et al
    Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.
    Am Heart J. 2020;222:73-82.
    PubMed     Abstract available

  49. LOUNGANI RS, Rehorn MR, Geurink KR, Coniglio AC, et al
    Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter.
    Am Heart J. 2020;222:26-29.
    PubMed     Abstract available

  50. LEERINK JM, Feijen ELAM, van der Pal HJH, Kok WEM, et al
    Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study.
    Am Heart J. 2020;219:89-98.
    PubMed     Abstract available

  51. LU DY, Ventoulis I, Liu H, Kudchadkar SM, et al
    Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
    Am Heart J. 2020;219:58-69.
    PubMed     Abstract available

  52. YAO X, McCoy RG, Friedman PA, Shah ND, et al
    ECG AI-Guided Screening for Low Ejection Fraction (EAGLE): Rationale and design of a pragmatic cluster randomized trial.
    Am Heart J. 2020;219:31-36.
    PubMed     Abstract available

    December 2019
  53. PUYMIRAT E, Simon T, de Bruyne B, Montalescot G, et al
    Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Am Heart J. 2019;222:1-7.
    PubMed     Abstract available

  54. ELMING MB, Hammer-Hansen S, Voges I, Nyktari E, et al
    Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI.
    Am Heart J. 2019 Dec 24. pii: S0002-8703(19)30351.
    PubMed     Abstract available

  55. KALRA R, Shenoy C
    Identifying nonischemic cardiomyopathy patients who would benefit from an implantable cardioverter-defibrillator: Can late gadolinium enhancement on cardiovascular magnetic resonance imaging help?
    Am Heart J. 2019 Dec 17. pii: S0002-8703(19)30352.

  56. SHLOFMITZ E, Torguson R, Zhang C, Craig PE, et al
    Impact of Intravascular Ultrasound on Outcomes Following PErcutaneous Coronary InterventioN in Complex Lesions (iOPEN Complex).
    Am Heart J. 2019;221:74-83.
    PubMed     Abstract available

  57. TRIPOLT NJ, Kolesnik E, Pferschy PN, Verheyen N, et al
    Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
    Am Heart J. 2019;221:39-47.
    PubMed     Abstract available

  58. FREITAS-FERRAZ AB, Rodes-Cabau J, Junquera Vega L, Beaudoin J, et al
    Transesophageal echocardiography complications associated with interventional cardiology procedures.
    Am Heart J. 2019;221:19-28.
    PubMed     Abstract available

  59. SIDIK NP, McEntegart M, Roditi G, Ford TJ, et al
    Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study.
    Am Heart J. 2019;221:48-59.
    PubMed     Abstract available

    October 2019
  60. JENTZER JC, Baran DA, van Diepen S, Barsness GW, et al
    Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients.
    Am Heart J. 2019;219:37-46.
    PubMed     Abstract available

    September 2019
  61. BEATON A, Okello E, Engelman D, Grobler A, et al
    Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Am Heart J. 2019;215:95-105.
    PubMed     Abstract available

  62. VAN MOURIK Y, Rutten FH, Bertens LCM, Cramer MJM, et al
    Clinical research study implementation of case-finding strategies for heart failure and chronic obstructive pulmonary disease in the elderly with reduced exercise tolerance or dyspnea: A cluster randomized trial.
    Am Heart J. 2019;220:73-81.
    PubMed     Abstract available

    August 2019
  63. CASTAGNO M, Menegon V, Monzani A, Zanetta S, et al
    Small-for-gestational-age birth is linked to cardiovascular dysfunction in early childhood.
    Am Heart J. 2019;217:84-93.
    PubMed     Abstract available

    July 2019
  64. RAMASAMY A, Serruys PW, Jones DA, Johnson TW, et al
    Reliable in vivo intravascular imaging plaque characterization: A challenge unmet.
    Am Heart J. 2019;218:20-31.
    PubMed     Abstract available

    June 2019
  65. MEHTA SR, Wood DA, Meeks B, Storey RF, et al
    Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation
    Am Heart J. 2019;215:157-166.
    PubMed     Abstract available

    May 2019
  66. MESSERLI M, Panadero AL, Giannopoulos AA, Schwyzer M, et al
    Enhanced radiation exposure associated with anterior-posterior x-ray tube position in young women undergoing cardiac computed tomography.
    Am Heart J. 2019;215:91-94.
    PubMed     Abstract available

  67. HARSKAMP RE, Granger TM, Clare RM, White KR, et al
    Peripheral blood metabolite profiles associated with new onset atrial fibrillation.
    Am Heart J. 2019;211:54-59.
    PubMed     Abstract available

  68. GUDNADOTTIR GS, James SK, Andersen K, Lagerqvist B, et al
    Outcomes after STEMI in old multimorbid patients with complex health needs and the effect of invasive management.
    Am Heart J. 2019;211:11-21.
    PubMed     Abstract available

    April 2019
  69. ZIMMERMANN FM, De Bruyne B, Pijls NHJ, Desai M, et al
    A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with
    Am Heart J. 2019;214:156-157.

  70. VAN ZANDVOORT LJC, Masdjedi K, Tovar Forero MN, Lenzen MJ, et al
    Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial.
    Am Heart J. 2019;213:66-72.
    PubMed     Abstract available

    February 2019
  71. MOUSSA PACHA H, Alraies MC
    In response to letter to the Editor: "Ultrasound guided radial artery catheterization: A superior technique for expert clinicians?"
    Am Heart J. 2019 Feb 23. pii: S0002-8703(19)30025.

  72. WHITE L, Vlok R, Melhuish T
    Ultrasound-guided radial artery catheterization: A superior technique for expert clinicians?
    Am Heart J. 2019 Feb 23. pii: S0002-8703(19)30024.

  73. BULLUCK H, Frohlich GM, Nicholas JM, Mohdnazri S, et al
    Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
    Am Heart J. 2019;211:60-67.
    PubMed     Abstract available

    January 2019
  74. ISRAELI Z, Lavi S, Pancholy SB, Nombela-Franco L, et al
    Radial versus femoral approach for saphenous vein grafts angiography and interventions.
    Am Heart J. 2019;210:1-8.
    PubMed     Abstract available

    December 2018
  75. DESCH S, Freund A, Graf T, Fichtlscherer S, et al
    Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: Design and rationale of the TOMAHAWK trial.
    Am Heart J. 2018;209:20-28.
    PubMed     Abstract available

  76. IBRAHIM NE, McCarthy CP, Shrestha S, Lyass A, et al
    Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.
    Am Heart J. 2018;209:36-46.
    PubMed     Abstract available

    October 2018
  77. LAMBRAKIS K, French JK, Scott IA, Briffa T, et al
    The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
    Am Heart J. 2018;208:11-20.
    PubMed     Abstract available

  78. PAGIDIPATI NJ, Mudrick DW, Chiswell K, Brucker A, et al
    Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease.
    Am Heart J. 2018;206:51-60.
    PubMed     Abstract available

    September 2018
  79. HARRISON RW, Radhakrishnan V, Allen JC Jr, Lam PS, et al
    The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts.
    Am Heart J. 2018;206:61-71.
    PubMed     Abstract available

    August 2018
  80. ELGENDY IY, Mansoor H, Li Q, Guo Y, et al
    Long-term mortality and estimated functional capacity among women with symptoms of ischemic heart disease: From the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
    Am Heart J. 2018 Aug 30. pii: S0002-8703(18)30252.
    PubMed     Abstract available

  81. LEE J, Nakanishi R, Li D, Shaikh K, et al
    Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis.
    Am Heart J. 2018 Aug 24. pii: S0002-8703(18)30249.
    PubMed     Abstract available

  82. WHITE WB, Jalil F, Wakefield DB, Kaplan RF, et al
    Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension.
    Am Heart J. 2018;205:21-30.
    PubMed     Abstract available

  83. DINOV B, Oebel S, Hilbert S, Loebe S, et al
    Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success.
    Am Heart J. 2018;204:68-75.
    PubMed     Abstract available

  84. MACK MJ, Abraham WT, Lindenfeld J, Bolling SF, et al
    Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Am Heart J. 2018;205:1-11.
    PubMed     Abstract available

    July 2018
  85. BURGESS SN, French JK, Nguyen TL, Leung M, et al
    The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarction.
    Am Heart J. 2018;205:31-41.
    PubMed     Abstract available

  86. STRANGE G, Celermajer DS, Marwick T, Prior D, et al
    The National Echocardiography Database Australia (NEDA): Rationale and methodology.
    Am Heart J. 2018 Jul 17. pii: S0002-8703(18)30202.
    PubMed     Abstract available

  87. FEYZ L, El Faquir N, Lemmert ME, Misier KR, et al
    Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation.
    Am Heart J. 2018;204:83-91.
    PubMed     Abstract available

  88. GUALANDRO DM, Puelacher C, LuratiBuse G, Lampart A, et al
    Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.
    Am Heart J. 2018;203:67-73.
    PubMed     Abstract available

    June 2018
  89. MOUSSA PACHA H, Alahdab F, Al-Khadra Y, Idris A, et al
    Ultrasound-guided versus palpation-guided radial artery catheterization in adult population: A systematic review and meta-analysis of randomized controlled trials.
    Am Heart J. 2018;204:1-8.
    PubMed     Abstract available

  90. ELFWEN L, Lagedal R, James S, Jonsson M, et al
    Coronary angiography in out-of-hospital cardiac arrest without ST elevation on ECG-Short- and long-term survival.
    Am Heart J. 2018;200:90-95.
    PubMed     Abstract available

  91. LATTUCA B, Barber-Chamoux N, Alos B, Sfaxi A, et al
    Impact of video on the understanding and satisfaction of patients receiving informed consent before elective inpatient coronary angiography: A randomized trial.
    Am Heart J. 2018;200:67-74.
    PubMed     Abstract available

    May 2018
  92. CASTEL AL, Toledano M, Tribouilloy C, Delelis F, et al
    Assessment of left ventricular size and function by 3-dimensional transthoracic echocardiography: Impact of the echocardiography platform and analysis software.
    Am Heart J. 2018;202:127-136.
    PubMed     Abstract available

  93. SAMAD Z, Shaw LK, Phelan M, Glower DD, et al
    Long-term outcomes of mitral regurgitation by type and severity.
    Am Heart J. 2018;203:39-48.
    PubMed     Abstract available

  94. KANG J, Koo BK, Hu X, Lee JM, et al
    Comparison of Fractional FLow Reserve And Intravascular ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with InteRmediate Stenosis (FLAVOUR): Rationale and design of a randomized clinical trial.
    Am Heart J. 2018;199:7-12.
    PubMed     Abstract available

    April 2018
  95. MUHLESTEIN JB, May HT, Galenko O, Knowlton KU, et al
    GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
    Am Heart J. 2018;202:27-32.
    PubMed     Abstract available

  96. BATCHELOR W, Dahya V, McGee D, Katopodis J, et al
    Ultrahigh-resolution ultrasound characterization of access site trauma and intimal hyperplasia following use of a 7F sheathless guide versus 6F sheath/guide combination for transradial artery PCI: Results of the PRAGMATIC trial.
    Am Heart J. 2018;198:75-83.
    PubMed     Abstract available

  97. CHEW DS, Wilton SB, Kavanagh K, Southern DA, et al
    Left ventricular ejection fraction reassessment post-myocardial infarction: Current clinical practice and determinants of adverse remodeling.
    Am Heart J. 2018;198:91-96.
    PubMed     Abstract available

  98. KINNAIRD T, Cockburn J, Gallagher S, Choudhury A, et al
    Temporal changes in radial access use, associates and outcomes in patients undergoing PCI using rotational atherectomy between 2007 and 2014: results from the British Cardiovascular Intervention Society national database.
    Am Heart J. 2018;198:46-54.
    PubMed     Abstract available

  99. BISHAWI M, Hattler B, Almassi GH, Spertus JA, et al
    Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial.
    Am Heart J. 2018;198:33-38.
    PubMed     Abstract available

    March 2018
  100. LAGEDAL R, Elfwen L, James S, Oldgren J, et al
    Design of DISCO-Direct or Subacute Coronary Angiography in Out-of-Hospital Cardiac Arrest study.
    Am Heart J. 2018;197:53-61.
    PubMed     Abstract available

    February 2018
  101. GIBBONS RJ, Carryer D, Liu H, Brady PA, et al
    Use of echocardiography in outpatients with chest pain and normal resting electrocardiograms referred to Mayo Clinic Rochester.
    Am Heart J. 2018;196:49-55.
    PubMed     Abstract available

  102. EGBE A, Khan AR, Miranda WR, Ammash NM, et al
    Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.
    Am Heart J. 2018;196:144-152.
    PubMed     Abstract available

    January 2018
  103. EGBE A, Khan AR, Khan SF, Anavekar NS, et al
    Role of Doppler echocardiography for cardiac output assessment in Fontan patients.
    Am Heart J. 2018;195:91-98.
    PubMed     Abstract available

  104. VEMULAPALLI S, Holmes DR Jr, Dai D, Matsouaka R, et al
    Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Am Heart J. 2018;195:1-13.
    PubMed     Abstract available

  105. MAURI L, Kario K, Basile J, Daemen J, et al
    A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Am Heart J. 2018;195:115-129.
    PubMed     Abstract available

    December 2017
  106. ILIESCU CA, Cilingiroglu M, Giza DE, Rosales O, et al
    "Bringing on the light" in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry).
    Am Heart J. 2017;194:83-91.
    PubMed     Abstract available

  107. LEE S, Kang DH, Kim DH, Song JM, et al
    Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
    Am Heart J. 2017;194:1-8.
    PubMed     Abstract available

    November 2017
  108. LEE PH, Lee JY, Lee CW, Han S, et al
    Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registry.
    Am Heart J. 2017;193:76-83.
    PubMed     Abstract available

  109. DOROS G, Massaro JM, Kandzari DE, Waksman R, et al
    Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach.
    Am Heart J. 2017;193:35-45.
    PubMed     Abstract available

    October 2017
  110. WAKSMAN R, Torguson R, Spad MA, Garcia-Garcia H, et al
    The Lipid-Rich Plaque Study of vulnerable plaques and vulnerable patients: Study design and rationale.
    Am Heart J. 2017;192:98-104.
    PubMed     Abstract available

  111. O'BYRNE ML, Shinohara RT, Grant EK, Kanter JP, et al
    Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.
    Am Heart J. 2017;192:85-97.
    PubMed     Abstract available

  112. KAUSHAL S, Wehman B, Pietris N, Naughton C, et al
    Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
    Am Heart J. 2017;192:48-56.
    PubMed     Abstract available

  113. JESSEE R, Peart E, Beineke P, Rosenberg S, et al
    Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease.
    Am Heart J. 2017;192:13-18.
    PubMed     Abstract available

  114. ADIR Y, Guazzi M, Offer A, Temporelli PL, et al
    Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Am Heart J. 2017;192:120-127.
    PubMed     Abstract available

    September 2017
  115. GUDNADOTTIR GS, Andersen K, Thrainsdottir IS, James SK, et al
    Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes.
    Am Heart J. 2017;191:65-74.
    PubMed     Abstract available

  116. AMELOOT K, De Deyne C, Ferdinande B, Dupont M, et al
    Mean arterial pressure of 65 mm Hg versus 85-100 mm Hg in comatose survivors after cardiac arrest: Rationale and study design of the Neuroprotect post-cardiac arrest trial.
    Am Heart J. 2017;191:91-98.
    PubMed     Abstract available

  117. HAYER MK, Edwards NC, Slinn G, Moody WE, et al
    A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.
    Am Heart J. 2017;191:37-46.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.